Deer Park, Illinois-based Eton Pharmaceuticals, Inc. is a specialty pharmaceutical company with a focus on developing, acquiring, and commercializing pharmaceutical products for rare diseases. Its offerings include ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age, Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency, Betaine Anhydrous for homocystinuria treatment, and dehydrated alcohol injection for the treatment of methanol poisoning. In addition to this, Eton Pharmaceuticals also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis, Alaway Preservative Free, a preservative-free ophthalmic product, EPRONTIA, a liquid formulation of topiramate, ZONISADE, a liquid formulation of zonisamide for the treatment of partial seizures in patients with epilepsy, and Lamotrigine for Oral Suspension for the treatment of epilepsy. The company was founded in 2017.
Eton Pharmaceuticals's ticker is ETON
The company's shares trade on the NASDAQ stock exchange
They are based in Deer Park, Illinois
There are 11-50 employees working at Eton Pharmaceuticals
It is etonpharma.com
Eton Pharmaceuticals is in the Healthcare sector
Eton Pharmaceuticals is in the Biotechnology industry
The following five companies are Eton Pharmaceuticals's industry peers:
- Cyclerion Therapeutics, Inc.